bepmed |

1683010
l 2005
CN

2301. Human papillomavirus type bivalent virus-like particle mixed protein antigen and construction method

Abstract

The present invention relates to human papillomavirus type bivalent virus-like particle mixture, and human papillomavirus type bivalent virus-like particle mixing protein antigen and its construction...

13:56 / cells / methods

1654028
l 2005
CN

2302. Tissue engineering complex grid shape stent forming method base on core dissolving technology

Abstract

The method of complicated tubular netted tissue engineering rack forming technology based on core dissolving technique belongs to the field of tissue engineering rack manufacturing...

13:56 / rest

1637136
l 2005
CN

2303. Laser prepn process of directionally arranged nanometer channel regulating cell

Abstract

The common medical polymer material to be used as cell culture substrate is treated through laser scanning to form micron/nanometer or submicon/nanometer channels before sterilization....

13:56 / rest

1687125
l 2005
CN

2304. Method for constructing, expressing and purifying human recombination factor and application

Abstract

The present invention relates to a human recombinant tissue factor, its construction, expression and purification method and application. Said method includes the following steps: recombining...

13:56 / cells / methods

1683441
l 2005
CN

2305. Process for preparing biologically degradable reverse temperature sensitive material

Abstract

The present invention relates to preparation process of biodegradable reverse temperature sensitive material used for medicine conveying system, cell embedment, biological tissue engineering and medical...

13:56 / methods / Scaffolds

1687133
l 2005
CN

2306. Monoclonal antibody of anti human immune deficiency virus I type 24 protein and application thereof

Abstract

The present invention to a monoclonal antibody for resisting human immune deficiency virus I type p24 protein and its application, belonging to the field of...

13:56 / rest

1.02005E+11
l 2005
DE

2307. Osteogenic matrix composite used for coating tissue engineering implants or scaffolds, comprises non-collagen extracellular matrix component integrated in non-crosslinked collagen fibrils

Abstract

Osteogenic matrix composite (A) comprises a collagen component (I) and a non-collagen extracellular matrix (ECM) component (or its derivatives) (II). (I) Comprises non-crosslinked collagen fibrils...

13:56 / Biomaterial / Scaffolds

1647778
l 2005
CN

2308. Method for preparing hole structure gradient changing spherical inner hole artificial bone

Abstract

The preparation process of artificial bone with spherical inner hole in gradient changing structure includes the following steps: mixing PVC balls and table salt crystal...

13:56 / rest

1609203
l 2005
CN

2309. Human ovary carcinoma resisting monoclonal antibody hybridoma cell line and its monoclonal antibody and application

Abstract

The present invention belongs to the field of biotechnology and cell engineering, and relates to monoclonal antibody hybridoma cell line and its construction process. Technology,...

13:56 / cells / methods

1587390
l 2005
CN

2310. Preparation and application of cell-eliminating pig corium substrate without cytotoxicity

Abstract

The preparation process of cell-eliminating pig corium substrate includes sustained vibration of the corium substrate in 0.5 mol/L NaOH solution compounded with thrice distilled water,...

13:56 / Biomaterial / cells

Author: admin

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract